347 related articles for article (PubMed ID: 26543666)
1. Novel applications of statins for bone regeneration.
Shah SR; Werlang CA; Kasper FK; Mikos AG
Natl Sci Rev; 2015 Mar; 2(1):85-99. PubMed ID: 26543666
[TBL] [Abstract][Full Text] [Related]
2. Mevalonate-suppressive dietary isoprenoids for bone health.
Mo H; Yeganehjoo H; Shah A; Mo WK; Soelaiman IN; Shen CL
J Nutr Biochem; 2012 Dec; 23(12):1543-51. PubMed ID: 22981371
[TBL] [Abstract][Full Text] [Related]
3. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity.
Staal A; Frith JC; French MH; Swartz J; Güngör T; Harrity TW; Tamasi J; Rogers MJ; Feyen JH
J Bone Miner Res; 2003 Jan; 18(1):88-96. PubMed ID: 12510809
[TBL] [Abstract][Full Text] [Related]
4. Pleiotropic effects of statins on the vascular tissue.
Ikeda U; Shimada K
Curr Drug Targets Cardiovasc Haematol Disord; 2001 Jun; 1(1):51-8. PubMed ID: 12769664
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory effects of HMG-CoA reductase inhibitors.
Danesh FR; Anel RL; Zeng L; Lomasney J; Sahai A; Kanwar YS
Arch Immunol Ther Exp (Warsz); 2003; 51(3):139-48. PubMed ID: 12894868
[TBL] [Abstract][Full Text] [Related]
6. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
Danesh FR; Kanwar YS
FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
[TBL] [Abstract][Full Text] [Related]
7. Pleiotropic effects of statins and related pharmacological experimental approaches.
Alegret M; Silvestre JS
Methods Find Exp Clin Pharmacol; 2006 Nov; 28(9):627-56. PubMed ID: 17200729
[TBL] [Abstract][Full Text] [Related]
8. Statins and cancer.
Vallianou NG; Kostantinou A; Kougias M; Kazazis C
Anticancer Agents Med Chem; 2014 Jun; 14(5):706-12. PubMed ID: 24295174
[TBL] [Abstract][Full Text] [Related]
9. Pleiotropic effects of statins and related pharmacological experimental approaches.
Alegret M; Silvestre JS
Timely Top Med Cardiovasc Dis; 2007 Apr; 11():E10. PubMed ID: 17473899
[TBL] [Abstract][Full Text] [Related]
10. Potential mechanisms and applications of statins on osteogenesis: Current modalities, conflicts and future directions.
Oryan A; Kamali A; Moshiri A
J Control Release; 2015 Oct; 215():12-24. PubMed ID: 26226345
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
Lennernäs H; Fager G
Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
[TBL] [Abstract][Full Text] [Related]
12. Pleiotropic effects of HMG-CoA reductase inhibitors.
Bocan TM
Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
[TBL] [Abstract][Full Text] [Related]
13. The role of pleiotropic effects of statins in dementia.
Crisby M
Acta Neurol Scand Suppl; 2006; 185():115-8. PubMed ID: 16866920
[TBL] [Abstract][Full Text] [Related]
14. Direct effects of statins on cells primarily involved in atherosclerosis.
Chen H; Ikeda U; Shimpo M; Shimada K
Hypertens Res; 2000 Mar; 23(2):187-92. PubMed ID: 10770267
[TBL] [Abstract][Full Text] [Related]
15. The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins.
Mo H; Jeter R; Bachmann A; Yount ST; Shen CL; Yeganehjoo H
Front Pharmacol; 2018; 9():1515. PubMed ID: 30662405
[TBL] [Abstract][Full Text] [Related]
16. Role of the cholesterol biosynthetic pathway in osteoblastic differentiation.
Viccica G; Vignali E; Marcocci C
J Endocrinol Invest; 2007; 30(6 Suppl):8-12. PubMed ID: 17721067
[TBL] [Abstract][Full Text] [Related]
17. Repurposing of statins via inhalation to treat lung inflammatory conditions.
Bradbury P; Traini D; Ammit AJ; Young PM; Ong HX
Adv Drug Deliv Rev; 2018 Aug; 133():93-106. PubMed ID: 29890243
[TBL] [Abstract][Full Text] [Related]
18. Statins as potential therapeutic agents in multiple sclerosis.
Stüve O; Prod'homme T; Youssef S; Dunn S; Neuhaus O; Weber M; Hartung HP; Steinman L; Zamvil SS
Curr Neurol Neurosci Rep; 2004 May; 4(3):237-44. PubMed ID: 15102350
[TBL] [Abstract][Full Text] [Related]
19. Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?
Balakumar P; Kathuria S; Taneja G; Kalra S; Mahadevan N
J Mol Cell Cardiol; 2012 Jan; 52(1):83-92. PubMed ID: 21968328
[TBL] [Abstract][Full Text] [Related]
20. Statin as a therapeutic agent in gastroenterological cancer.
Uemura N; Hayashi H; Baba H
World J Gastrointest Oncol; 2022 Jan; 14(1):110-123. PubMed ID: 35116106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
